Published in Nature on May 02, 1996
Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. Proc Natl Acad Sci U S A (1997) 1.19
GA-binding protein factors, in concert with the coactivator CREB binding protein/p300, control the induction of the interleukin 16 promoter in T lymphocytes. Proc Natl Acad Sci U S A (1999) 1.00
The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci U S A (1996) 4.48
HIV suppression by interleukin-16. Nature (1995) 3.94
Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial. Lancet (1999) 2.95
Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J Virol (2001) 2.79
Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol Cell (2000) 2.77
Competing demands in the office visit: what influences mammography recommendations? J Am Board Fam Pract (2001) 2.72
Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev (1999) 2.57
Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc Natl Acad Sci U S A (1993) 2.43
Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity (1995) 2.40
Expression cloning of human and rat renal cortex Na/Pi cotransport. Proc Natl Acad Sci U S A (1993) 2.33
Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDV. Virology (1993) 2.32
Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. J Clin Oncol (1993) 2.11
Human anti-self antibodies with high specificity from phage display libraries. EMBO J (1993) 2.08
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol (1987) 1.99
Antibodies to simian T-lymphotropic retrovirus type III in African green monkeys and recognition of STLV-III viral proteins by AIDS and related sera. Lancet (1985) 1.96
Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K. J Virol (1995) 1.91
Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration. J Neurosci (1998) 1.87
Distinguishable transformation-defective phenotypes among temperature-sensitive mutants of Rous sarcoma virus. J Virol (1977) 1.79
Soluble CD4 enhances simian immunodeficiency virus SIVagm infection. J Virol (1990) 1.79
Eight-year follow-up study of brain atrophy in patients with MS. Neurology (2002) 1.78
Expression cloning of a cDNA from rabbit kidney cortex that induces a single transport system for cystine and dibasic and neutral amino acids. Proc Natl Acad Sci U S A (1992) 1.78
Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 coreceptor. J Biol Chem (1999) 1.76
Simian immunodeficiency virus (SIV) from sun-tailed monkeys (Cercopithecus solatus): evidence for host-dependent evolution of SIV within the C. lhoesti superspecies. J Virol (1999) 1.72
Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals. AIDS (1994) 1.68
Regulation of MCSF receptors on microglia in the normal and injured mouse central nervous system: a quantitative immunofluorescence study using confocal laser microscopy. J Comp Neurol (1998) 1.67
Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation (1997) 1.67
Inhibition of HIV-1 replication and NF-kappa B activity by cysteine and cysteine derivatives. AIDS (1991) 1.57
Regional differences in the prevalence of known Type 2 diabetes mellitus in 45-74 years old individuals: results from six population-based studies in Germany (DIAB-CORE Consortium). Diabet Med (2012) 1.56
An observational study of attending rounds. J Gen Intern Med (1993) 1.55
Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc Natl Acad Sci U S A (1997) 1.53
Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. J Pediatr (1999) 1.52
Molecularly cloned simian immunodeficiency virus SIVagm3 is highly divergent from other SIVagm isolates and is biologically active in vitro and in vivo. J Virol (1989) 1.49
Isolation of human immunodeficiency virus-related simian immunodeficiency viruses from African green monkeys. Proc Natl Acad Sci U S A (1989) 1.47
Development of a quasispecies of human immunodeficiency virus type 1 in vivo. Proc Natl Acad Sci U S A (1992) 1.44
Detection of plasma viremia in human immunodeficiency virus-infected individuals at all clinical stages. J Clin Microbiol (1993) 1.40
Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K. J Virol (1999) 1.39
Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans. J Pharm Sci (1979) 1.37
Thyroid cancer following scalp irradiation. Radiology (1977) 1.37
Characterization of the antibody response specific for the human endogenous retrovirus HTDV/HERV-K. J Virol (1997) 1.37
Human teratocarcinomas cultured in vitro produce unique retrovirus-like viruses. J Gen Virol (1984) 1.36
The function of the chloroplast 2-cysteine peroxiredoxin in peroxide detoxification and its regulation. J Exp Bot (2002) 1.34
Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeys. Proc Natl Acad Sci U S A (1990) 1.33
First confirmed autochthonous case of human Babesia microti infection in Europe. Eur J Clin Microbiol Infect Dis (2007) 1.33
Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus. Virology (1996) 1.30
Electrophysiological characterization of the flounder type II Na+/Pi cotransporter (NaPi-5) expressed in Xenopus laevis oocytes. J Membr Biol (1997) 1.30
Treatment of thyroid carcinoma in dogs by surgical resection alone: 20 cases (1981-1989). J Am Vet Med Assoc (1995) 1.30
Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes. Immunology (2000) 1.29
Somatotopic organization of human secondary somatosensory cortex. Cereb Cortex (2001) 1.28
Stimulation of system y(+)-like amino acid transport by the heavy chain of human 4F2 surface antigen in Xenopus laevis oocytes. Proc Natl Acad Sci U S A (1992) 1.27
Cellular mechanisms in proximal tubular reabsorption of inorganic phosphate. Am J Physiol (1991) 1.26
Developing national epidemiologic capacity to meet the challenges of emerging infections in Germany. Emerg Infect Dis (2001) 1.26
Development of a matrix to evaluate the threat of biological agents used for bioterrorism. Cell Mol Life Sci (2006) 1.26
HERV-K: the biologically most active human endogenous retrovirus family. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.26
Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor. Proc Natl Acad Sci U S A (2001) 1.24
Simian immunodeficiency virus of African green monkeys is apathogenic in the newborn natural host. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.23
Practice patterns of family physicians in practice-based research networks: a report from ASPN. Ambulatory Sentinel Pratice Network. J Am Board Fam Pract (1999) 1.23
Identification of upregulated genes in scrapie-infected brain tissue. J Virol (2000) 1.23
Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. J Infect Dis (1986) 1.22
Renal Na(+)-phosphate cotransport in murine X-linked hypophosphatemic rickets. Molecular characterization. J Clin Invest (1994) 1.22
The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides. J Immunol (1994) 1.21
A mouse model of Streptococcus pneumoniae meningitis mimicking several features of human disease. Acta Neuropathol (2001) 1.21
Genome analysis and reverse transcriptase activity of human teratocarcinoma-derived retroviruses. J Gen Virol (1987) 1.20
Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. Proc Natl Acad Sci U S A (1997) 1.19
Establishment and characterization of molecular clones of porcine endogenous retroviruses replicating on human cells. J Virol (2000) 1.19
Expression cloning of a human renal cDNA that induces high affinity transport of L-cystine shared with dibasic amino acids in Xenopus oocytes. J Biol Chem (1993) 1.18
Impaired specific cellular response to HTLV-III before other immune defects in patients with HTLV-III infection. N Engl J Med (1986) 1.18
National survey of neonatal transfusion practices: I. Red blood cell therapy. Pediatrics (1993) 1.17
Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium. Mult Scler (2003) 1.16
Localization of NaPi-1, a Na/Pi cotransporter, in rabbit kidney proximal tubules. II. Localization by immunohistochemistry. Pflugers Arch (1993) 1.16
Complete nucleotide sequence of a simian immunodeficiency virus from African green monkeys: a novel type of intragroup divergence. Virology (1990) 1.15
Development of vivo of genetic variability of simian immunodeficiency virus. Proc Natl Acad Sci U S A (1991) 1.15
Differential regulation of cellular tropism and sensitivity to soluble CD4 neutralization by the envelope gp120 of human immunodeficiency virus type 1. J Virol (1994) 1.15
Lack of HIV-1 V3 region sequence diversity in two haemophiliac patients infected with a putative biologic clone of HIV-1. AIDS (1991) 1.14
[Prevention, diagnosis, therapy, and follow-up of lung cancer]. Pneumologie (2010) 1.14
Changes in functional status related to health maintenance visits to family physicians. J Fam Pract (2000) 1.14
High virus loads in naturally and experimentally SIVagm-infected African green monkeys. Virology (2001) 1.12
Expression of Na(+)-independent amino acid transport in Xenopus laevis oocytes by injection of rabbit kidney cortex mRNA. Biochem J (1992) 1.12
Natural human antibodies reactive with primate type-C viral antigens. Proc Natl Acad Sci U S A (1977) 1.12
Copper-modulated gene expression and senescence in the filamentous fungus Podospora anserina. Mol Cell Biol (2001) 1.12
Lack of dichotomy between virus load of peripheral blood and lymph nodes during long-term simian immunodeficiency virus infection of African green monkeys. Virology (1996) 1.11
Characterization of human endogenous retrovirus type K virus-like particles generated from recombinant baculoviruses. Virology (1997) 1.11
Common tumor-specific surface antigens on cells of different species transformed by avian RNA tumor viruses. Virology (1972) 1.10
CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine. Proc Natl Acad Sci U S A (1994) 1.09
The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients. AIDS (1994) 1.08
Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS. Neurology (2001) 1.08